SPY408.32+8.23 2.06%
DIA327.10+4.32 1.34%
IXIC11,984.52+321.73 2.76%

Horizon Therapeutics Says Uplizna Wins EU Approval to Treat Neuromyelitis Optica Spectrum Disorder Subtype

MT Newswires · 05/01/2022 23:43

Please log in to view news